Ikarian Capital, LLC Gossamer Bio, Inc. Put Options Transaction History

Ikarian Capital, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Nov 14, 2022	BUY	$7.21 - $14.88 $125,454 - $258,912	17,400 New	17,400 $209,000
Q1 2022 May 13, 2022	BUY	$8.44 - $12.49 $125,755 - $186,101	14,900 New	14,900 $129,000
Q1 2020 May 15, 2020	SELL	$8.0 - $15.48 $6.17 Million - $11.9 Million	-771,100 Closed	0 $0
Q4 2019 Jan 31, 2020	BUY	$14.82 - $26.79 $11.4 Million - $20.7 Million	771,100 New	771,100 $12.1 Million

108

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $80.8M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.